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Almost twenty five years ago, Liebowitz and colleagues called 
social phobia a “neglected anxiety disorder”,1 since it was relatively 
little investigated when compared to the other anxiety disorders. The 
authors pointed out that many uncertainties remained regarding 
its classification, prevalence, severity, etiology, assessment, and 
treatment. They also highlighted that social phobia (also known as 
social anxiety disorder, SAD) was a fertile area for psychobiological 
and clinical investigation. This idea was supported by the fact that 
in 1985 no more than two dozen papers on social phobia were 
available via Medline.
Over the past decades, since the publication of that seminal 
manuscript, significant progress has been made in the literature 
on SAD, especially in relation to its epidemiology, diagnosis, 
neurobiology, and the pharmacological and psychotherapeutic 
management of the condition. However, the number of articles 
published since SAD was included in the formal diagnostic 
classification of DSM-III, in 1980, is still modest when compared 
to the other anxiety disorders – especially post-traumatic stress 
disorder (PTSD) - Figure 1a. It is particularly surprising considering 
that SAD is the most commonly found anxiety disorder (Figure 1b), 
with early onset, chronic course, often associated with considerable 
functional impairment and comorbid psychiatric disorders;2 and 
remission rarely occurs without therapeutic intervention.
There are several possibilities for these discrepancies. As 
opposed to other psychiatric disorders, some authors have 
proposed a dimensional approach to the classification of SAD 
within a continuum of symptom severity, number of psychiatric 
comorbidities, degree of suffering and impairment, instead of 
having a more valid category.2 This led some people to speculate 
on whether SAD is merely shyness or a condition created by the 
pharmaceutical industry to expand the market. Additionally, in the 
recent past, SAD was still thought of as having a purely psychological 
nature, whereas other anxiety disorders such as panic disorder (PD), 
obsessive-compulsive disorder (OCD), and PTSD have long been 
linked to brain abnormalities. For instance, a recent review noted 
the scarce number of morphometric Magnetic Resonance Imaging 
studies on SAD when compared to other anxiety disorders.3
Despite the high prevalence of the disorder and considerable level 
of functional impairment associated with it, SAD patients are less 
likely than people with other anxiety disorders to seek help for their 
psychiatric problems. In a recent epidemiological survey from our 
group, 10.2% (n = 235 out of 2319) of university students met 
DSM-IV criteria for SAD, but only 0.8% (n = 2 out of 235) had been 
diagnosed or used medication to treat their condition.4 Similar figures 
have been observed in clinical settings as well as in the ECA Duke 
study, in which only 3% of SAD patients reported seeking help for 
social anxiety.5 This fact may be related to the essential characteristic 
of SAD of presenting anxiety when feeling under scrutiny, which 
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may keep patients from revealing their social anxiety symptoms to 
a “potential authority” (e.g., physician) without being asked to do 
so. Therefore, clinicians normally do not diagnose SAD unless they 
ask about their patients’ social fears and avoidances, particularly 
when social phobia is not the primary reason for seeking treatment.
Another potential reason for the SAD under-recognition by patients 
is the relative low attention given by the general media for social 
phobia when compared to other anxiety disorders. While television 
programs, newspaper articles, magazine reports, and even movies 
have been dedicated to PD in the 1980s, to OCD in the 1990s, 
and to PTSD in the 2000s, SAD is still waiting for its turn in the 
spotlights.
We can conclude that in the last few years a growing body of 
data on the pathogenesis of SAD has been consolidated, including 
the biological mechanisms that come from pharmacological 
and behavioral challenges, functional neuroimaging and 
cognitive-behavioral approaches. Effective pharmacological and 
psychotherapeutic interventions are available. However, many 
challenges remain. In particular, research advances have not been 
fully translated to the clinical community, as too many patients 
remain undiagnosed and under-treated. Thus, although additional 
research at all levels is desirable and needed, overcoming the current 
under-recognition and lack of awareness about this condition is the 
first step to turn SAD from the ‘Ugly Duckling’ into a ‘graceful swan’ 
among the anxiety disorders.
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